Asston Pharmaceuticals IPO
Asston Pharmaceuticals IPO
Overview
Asston Pharmaceuticals IPO is a bookbuilding of ₹27.56 crores. The issue is entirely a fresh issue of 22.41 lakh shares. Asston Pharmaceuticals IPO opens for subscription on July 9, 2025 and closes on July 11, 2025. The allotment for the Asston Pharmaceuticals IPO is expected to be finalized on Monday, July 14, 2025. Asston Pharmaceuticals IPO will be list on BSE SME with a tentative listing date fixed as Wednesday, July 16, 2025. Asston Pharmaceuticals IPO price band is set at ₹115 to ₹123 per share. The lot size for an application is 1000. The minimum amount of investment required by an individual investor (retail) is ₹2,30,000 (2000 shares). The minimum lot size investment for HNI is 3 lots (3,000 shares) amounting to ₹3,69,000. Sobhagya Capital Options Ltd is the book-running lead manager of the Asston Pharmaceuticals IPO, while Maashitla Securities Private Limited is the registrar for the issue.The market maker for Asston Pharmaceuticals IPO is JSK Securities and Services Private Limited. Refer to Asston Pharmaceuticals IPO RHP for detailed information.
Total Shares
22,41,000
Issue Size
₹27.56 Cr
Price Band
₹115 – ₹123
Lot Size
1000 shares
Min. Investment
₹2,46,000
Max. Investment
₹2,46,000
Open Date
09 Jul, 2025
Close Date
11 Jul, 2025
Allotment
14 Jul, 2025
Listing
16 Jul, 2025
Max. Investment
₹2,46,000
Announced
09 Jul, 2025
Opening Date
09 Jul, 2025
Closing Date
11 Jul, 2025
Basis of Allotment
14 Jul, 2025
Initiation of Refunds
15 Jul, 2025
Credit of Shares
15 Jul, 2025
Listing Date
16 Jul, 2025
Live GMP
Est. Listing: ₹153
Apply via UPI in 5 minutes
Choose your broker • Zero commission on IPO
About Asston Pharmaceuticals IPO
Incorporated in 2019, Asston Pharmaceuticals Limited is engaged in the business of pharmaceuticals, specializing in exporting healthcare products globally.
The company offers a diverse range of products, including tablets, capsules, sachets, and syrups. Its product portfolio encompasses various therapeutic categories, such as analgesics, antibiotics, antifungals, vitamins, and more.
The company manufactures pharmaceutical products for direct sales and also on a contract manufactur
Asston Pharmaceuticals IPO Share Price
Issue Breakdown
Shareholding
Dilution: 35.7% increase in shares
Asston Pharmaceuticals IPO Promoter Holding
Asston Pharmaceuticals IPO Financial Health
Asston Pharmaceuticals Limited's revenue increased by 62% and profit after tax (PAT) rose by 218% between the financial year ending with March 31, 2025 and March 31, 2024.
Asston Pharmaceuticals IPO Lot Size
Investors can bid for a minimum of 2,000 shares and in multiples of 1,000 shares there of. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 2000 | ₹2,46,000 |
| Individual investors (Retail) (Max) | 2 | 2000 | ₹2,46,000 |
| HNI (Min) | 3 | 3000 | ₹3,69,000 |
(All values in CR)
Asston Pharmaceuticals IPO Valuations
The market capitalization of Asston Pharmaceuticals IPO is ₹104.70 Cr. KPI as of Mon, Mar 31, 2025.
| Metric | Value |
|---|---|
| ROE | 50.56 |
| ROCE | 51.25 |
| Debt/Equity | 0.68 |
| RoNW | 40.36 |
| PAT Margin | 17.27 |
| EBITDA Margin | 24.60 |
| Price to Book Value | 12.07 |
(All values in CR)
Asston Pharmaceuticals IPO Strength & Risk
Asston Pharmaceuticals IPO Strength:
Formulation Expertise: Proven capabilities in developing pharmaceutical formulations across therapeutic segments.
Experienced Promoters: Led by a team with deep industry knowledge and long-standing business experience in pharma.
Wide Range of Products: Offers a diversified portfolio catering to various chronic and acute conditions, ensuring revenue stability.
Strategic Location: Manufacturing unit strategically located in Gujarat, offering logistical advantages for raw material procurement and exports.
Skilled Workforce: Technically qualified and experienced staff ensuring quality control, regulatory compliance, and operational efficiency.
Asston Pharmaceuticals IPO Risk:
Dependence on Limited Customers: A high share of revenue from a few clients poses concentration risk.
Stringent Regulatory Compliance: Subject to domestic and international pharmaceutical regulations; any non-compliance could impact operations.
Pricing Pressure: Competitive pricing in the pharma industry and government price controls can affect profit margins.
Raw Material Volatility: Reliance on imports and price fluctuations of APIs (Active Pharmaceutical Ingredients) may impact cost structure.
Working Capital Intensive: High working capital requirements for inventory, R&D, and receivables can affect liquidity.
Asston Pharmaceuticals IPO Subscriptions
| Investor Category | Subscription (times) | Shares Offered | Shares bid for | Total Amount (Rs Cr.) |
|---|---|---|---|---|
| Anchor | 1.00 | 6,35,000 | 6,35,000 | 7.81 |
| Market Maker | 1.00 | 1,13,000 | 1,13,000 | 1.39 |
| Qualified Institutions | 85.76 | 4,25,000 | 3,64,49,000 | 448.32 |
| Non-Institutional Buyers | 353.14 | 3,22,000 | 11,37,10,000 | 1 |
| bNII (bids above ₹10L) | 424.47 | 2,15,000 | 9,12,62,000 | 1 |
| sNII (bids below ₹10L) | 210.85 | 1,07,000 | 2,25,61,000 | 277.5 |
| Individual Investors (IND category bidding for 2 Lots) | 172.06 | 7,46,000 | 12,83,58,000 | 1 |
| Total | 186.55 | 14,93,000 | 27,85,17,000 | 3 |
Asston Pharmaceuticals SME IPO GMP
Asston Pharmaceuticals SME IPO last GMP is ₹30, last updated Jul 11th 2025 05:56 PM. With the price band of 123.00, Asston Pharmaceuticals SME IPO's estimated listing price is ₹153 (cap price + today's GMP).The expected percentage gain/loss per share is 24.39%. >> Asston Pharmaceuticals SME IPO Retail Subject to Sauda: ₹22800 The lowest GMP is ₹10.00, while the highest GMP is ₹30.00.
Last updated 11 Jul, 2025 · Source: aggregated grey-market dealers
| Date | IPO Price | GMP | Sub2 Sauda | Est. Listing | Est. Profit | Updated |
|---|---|---|---|---|---|---|
| 11 Jul, 2025 | 123 | ₹30 | 22800 | ₹153 (24.39%) | 30000 | 11 Jul, 2025 |
| 10 Jul, 2025 | 123 | ₹30▲ | 22800 | ₹153 (24.39%) | 30000 | 10 Jul, 2025 |
| 09 Jul, 2025 | 123 | ₹25▲ | 19000 | ₹148 (20.33%) | 25000 | 09 Jul, 2025 |
| 08 Jul, 2025 | 123 | ₹15▲ | 11400 | ₹138 (12.20%) | 15000 | 08 Jul, 2025 |
| 07 Jul, 2025 | 123 | ₹10 | 7600 | ₹133 (8.13%) | 10000 | 07 Jul, 2025 |
| 06 Jul, 2025 | 123 | ₹10 | 7600 | ₹133 (8.13%) | 10000 | 06 Jul, 2025 |
| 05 Jul, 2025 | 123 | ₹10 | 7600 | ₹133 (8.13%) | 10000 | 05 Jul, 2025 |
| 04 Jul, 2025 | 123 | ₹10 | 7600 | ₹133 (8.13%) | 10000 | 04 Jul, 2025 |
Disclaimer: GMP is an unofficial signal from grey-market dealers and is not regulated by SEBI. Use it alongside subscription data and other research for informed decision-making.
How to Apply for Asston Pharmaceuticals IPO
Login to Your Trading App
Open Zerodha, Upstox, Groww, Angel One, or any brokerage app.
Go to IPO Section
Find Asston Pharmaceuticals IPO under the IPO section. Select it and enter your bid details — choose lot size and price (cut-off price recommended).
Enter UPI ID and Submit
Provide your UPI ID linked to your bank account and submit the application.
Approve Mandate on UPI App
Open your UPI app (Google Pay, PhonePe, Paytm, BHIM) and approve the IPO payment request.
Application Confirmed
Your funds will be blocked in your account until the IPO allotment process is completed.